Abstracts


Presented at the American College of Cardiology 2019, Scientific Session

Gupta M., Zawadka M., Aljenedil S., Kajil M., Bewick D., Gaudet D., Hegele R., Lonn E., Ngui D., Ruel I., Singh N., and Genest J. The high prevalence of familial hypercholesterolemia in a population of ASCVD patients with LDL-C above target: an analysis from the REACT registry. JACC Volume 73, Issue 9 Supplement 1, March 2019

Poster Available
Members only content. Please register or login to view


Manuscripts

Alothman L., MD, Zawadka M., Aljenedil S., Kajil M., Bewick D., Gaudet D., Hegele R., Lonn E., Ngui D., Ruel I., Tsigoulis M., Singh N., Genest J., and Gupta M., for the REACT Targets Investigators. Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm. CJC Open 1 (2019) 190-197

Abstracts


Presented at the American Cardiology of Cardiology 2018, Scientific Session

Ha, A, Labos C., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini G.B, Gladstone D., Lockwood E., Shuaib A., Chan W., Singh N. and Gupta M. Factors Associated With Impaired Quality Of Life Among Atrial Fibrillation Patients In Real-world Clinical Practice: Insights From The Prospective SPRINT-AF Registry. JACC vol. 71 no. 11 Supplement A520

Poster Available
Members only content. Please register or login to view


Presented at the American Cardiology of Cardiology 2018, Scientific Session

Ha, A, Labos C., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini G.B, Gladstone D., Lockwood E., Shuaib A., Chan W., Singh N. and Gupta M. What Factors Influence The Choice Of Apixaban, Rivaroxaban, Or Dabigatran For Stroke Prevention Among Atrial Fibrillation. JACC Volume 71, Issue 11 Supplement, March 2018

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2018, Scientific Session

Labos C., Ha A., Dorian P., Tsigoulis M., Kajil M., Cox J., Mancini J., Gladstone D., Lockwood E., Shuaib A., Singh N., and Gupta M. Persistence of oral anticoagulant use among Canadian atrial fibrillation patients: One-year results from the prospective SPRINT-AF registry. Can J Cardiol. Volume 34, Issue 10, Supplement 1, Pages S4–S5


Presented at the Canadian Cardiovascular Congress 2018, Scientific Session

Gupta M., Zawadka M., Aljenedil S., Kajil M., Bewick D., Gaudet D., Hegele R., Lonn E., Ngui D., Ruel I., Singh N., and Genest J. The high prevalence of familial hypercholesterolemia in a population of ASCVD patients with LDL-C above target: an analysis from the REACT registry. Can J Cardiol. Volume 34, Issue 10, Supplement 1, Page S1


Manuscripts

Ridker P., Everett B., Pradhan A., MacFadyen J., Solomon D., Zaharris E., Mam V., Hasan A., Rosenberg Y., Iturriaga E., Gupta M., Tsigoulis M., Verma S., Clearfield M., Libby P., Goldhaber S., Seagle R., Ofori C., Saklayen M., Butman S., Singh N., Le May M., Bertrand O., Johnston J., Paynter N., and Glynn R., for the CIRT Investigators. Low-Does Methotrexate for the Prevention of Atherosclerotic Events. NEJM; Nov. 19, 2018; DOI: 10.1056/NEJMoa1809798

Abstracts


Presented at the American College of Cardiology 2017, Scientific Session

Gupta M.,, Wu Y., Kajil M., Tsigoulis M., Cox J., Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini J., Shuaib A., Singh N., and Ha A. Concomitant use of antiplatelet and oral anticoagulation among patients with atrial fibrillation: Insights from the prospective SPRINT-AF registry. JACC vol. 69 no. 11 Supplement 452

Poster Available
Members only content. Please register or login to view


Presented at the European Heart Association 2017, Scientific Session

Gupta M. , Labos C., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini G.B.J. , Fournier C., Gladstone D., Lockwood E, Shuaib A., Singh N., and Ha A. Which factors influence the choice of a non-vitamin K oral anticoagulant over warfarin for stroke prevention among atrial fibrillation patients? Insights from the prospective SPRINT-AF registry. European Heart Journal ( 2017 ) 38 ( Supplement ), 764-765

Poster Available
Members only content. Please register or login to view


Presented at the European Heart Association 2017, Scientific Session

Jayaprakash H.K., Labos C., Shuaib A., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini J., Fournier C., Gladstone D., Lockwood E., Singh N., Ha A., Gupta M. Do atrial fibrillation patients with history of cerebrovascular accidents receive guideline-concordant stroke preventive therapies? Insights from the prospective SPRINT-AF registry. European Heart Journal ( 2017 ) 38 ( Supplement ), 82-83

Poster Available
Members only content. Please register or login to view


Presented at the European Heart Association 2017, Scientific Session

Ha A., Kajil M., Tsigoulis M., Labos C., Cox J., Dorian P., Mancini J., Fournier C., Gladstone D., Lockwood E., Shuaib A., Singh N., Gupta M. Antithrombotic use amongst patients at low stroke risk as defined by the CHA2DS2-VASc score: Insight from the prospective SPRINT-AF registry. European Heart Journal ( 2017 ) 38 ( Supplement ), 775

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2017, Scientific Session

Labos C., Ha A., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini J., Gladstone D., Lockwood E., Shauib A., Sikri H., Singh N., and Gupta M. Appropriateness of non-vitamin K oral anticoagulant dosing among Canadian atrial fibrillation patients. Can J Cardiol. Oct. 2017, Volume 33, Issue 10, Supplement, Page S189

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2017, Scientific Session

Gupta M., Ha A., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini J., Gladstone D., Lockwood E., Shuaib A., Sikri H., Singh N., and Labos C. Adequacy of hypertension control among patients with atrial fibrillation at high cardiovascular risk: Insights from a Canadian prospective registry. Circulation. 2017;136:A16503


Presented at the American Heart Association 2017, Scientific Session

Labos C., Ha A., Kajil M., Tsigoulis M., Cox J., Dorian P., Mancini J., Gladstone D., Lockwood E., Shuaib A., Sikri H., Singh N., and Gupta M. Rates and patterns of inappropriate dosing for non-vitamin K oral anticoagulant among Canadian atrial fibrillation patients: Insights from a prospective registry. Circulation. 2017;136:A16633

Abstracts


Presented at the Canadian Stroke Congress 2016, Scientific Session

Shuaib A., Ha A., Kajil M., Tsigoulis M., Dhillon P., Cox J., Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini JB., Singh N., and Gupta M. A cross Canada assessment of management of patients with a history of TIA or stroke related to atrial fibrillation: Insights from SPRINT-AF registry. Int J Stroke September 2016 vol. 11no. 2 suppl 4-88;Page 4


Presented at the Canadian Cardiovascular Congress 2016, Scientific Session

Ha A., Kajil M., Tsigoulis M., Dhillon P., Cox J., Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini JB., Shuaib A., Singh N. and Gupta M. Patterns of antithrombotic use in relation to the CHA2DS2-VASC and the CHADS2-65 stroke risk score in contemporary practice: Insights from a prospective Canadian atrial fibrillation (SPRINT-AF) registry. Can J Cardiol. October 2016 Volume 32, Issue 10, Supplement 1, Pages S158–S159

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2016, Scientific Session

Ha A., Kajil M., Tsigoulis M., Dhillon P., Cox J., Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini JB., Shuaib A., Singh N., and Gupta M. Sex differences in stroke risk profile, stroke prevention therapy use and treatment satisfaction in a contemporary cohort of patients with atrial fibrillation: Insights from SPRINT-AF. Circulation. 2016;134:A19182

Poster Available
Members only content. Please register or login to view


Manuscripts

Gupta M., Paul S, Kajil M., Ostrovski I., Tsigoulis M., Verma S., and Singh N. Acetylsalicilic acid use in Primary Prevention in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Curr Res Cardiol. 2016;3(3):67-70

Gupta M., Tsigoulis M., Kajil M., Verma S., and Singh N. Audit of cardiovascular risk assessment and lipid management by Canadian primary care physicians. Curr Res Cardiol. Summer 2016; Vol 3 No 2: 33-37.

Abstracts


Presented at the American College of Cardiology 2015, Scientific Session

Harpreet S., Bajaj H., Sheikh S., Gill-David S., Hirjikaka S., Tsigoulis M., and Gupta M. High rate of progression to dysglycemia in a secondary prevention cohort over five years: findings from the PRACTICE Registry. JACC 2015; March 17, 2015 Volume 65, Issue 10S

Poster Available
Members only content. Please register or login to view


Presented at the American College of Cardiology 2015, Scientific Session

Gupta M., Singh N., Tsigoulis M., Kajil M., Cox J., Dorian P., Mancini G.B.,  and Ha A. Underuse of Full Dose Factor Xa Inhibition in Atrial Fibrillation: Insights the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry.  JACC: 2015; March 17, 2015, 65(10_S)

Poster Available
Members only content. Please register or login to view


Presented at the European Society of Cardiology 2015, Scientific Session

Bajaj H., Sheikh S., Gill-David S., Hirjikaka S., Tsigoulis M., and Gupta M. Deterioration of glycemic control in South Asians vs. White Caucasians with diabetes and concomitant coronary artery disease – analysis from the PRACTICE Registry. European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 121-122

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2015, Scientific Session

Kaushal, M. Kajil, M. Tsigoulis, S. Gill, N. Singh, A.T. Yan, M. Gupta. The risk of obstructive sleep apnea in a healthy, middle-aged North American population: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) study. CJC Volume 31, Issue 10, Supplement, Pages S301–S302.

Poster Available
Members only content. Please register or login to view


Manuscripts

Law TK., MD, Yan AT., Gupta A., Kajil M., Tsigoulis M., Singh N., Verma S., nd Gupta M. Primary Prevention of Cardiovascular Disease: Global Cardiovascular Risk Assessment and Management in Clinical Practice. European Heart Journal – Quality of Care and Clinical Outcomes; published online June 2 2015

Andrew C.T. Ha, Singh N., Cox J., Mancini J., Dorian P., Fournier C.,, Gladstone D., Lockwood E., Shuaib A., Kajil M., Tsigoulis M., and Gupta M. Patterns of oral anticoagulant use for stroke prevention in contemporary Canadian atrial fibrillation practice – insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry. Can J Cardiol; May 03, 2015, Vol. 32(2), 204-210

Gupta M., Smitzko P., Singh N., Tsigoulis M., Kajil M., and Stone J. Management and Control of Uncomplicated Hypertension in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Can J Cardiol; May 2015, Vol. 31(5), 664-670

Abstracts


Presented at the American College of Cardiology 2014, Scientific Session

Gupta, M., Ha, A., Cox, J., Dorian, P., Fournier, C., Gladstone, D., Lockwood, E., Mancini J., Saldanha C., Shuaib, A., Singh N., Kajil, K., Tsigoulis, M., and Verma, S. Factors associated with new oral anticoagulant versus vitamin K antagonist use in atrial fibrillation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry. JACC. 2014;63 (12_S), A331

Poster Available
Members only content. Please register or login to view


Presented at the American College of Cardiology 2014, Scientific Session

Verma, S., Cox, J., Dorian, P., Fournier C., Gladstone, D., Lockwood, E., Mancini, J., Saldanha, C., Shuaib, A., Singh, N., Kajil, M., Tsigoulis, M., and Gupta, M. Disagreement between physician-reported and scoring system-based stroke and bleeding risks in patients with atrial fibrillation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry. JACC. 2014;63(12_S), A423

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2014, Scientific Session

Ha A., Verma S., Cox J., Dorian P., Gladstone D., Lockwood E., Mancini G.B.J., Saldanha C., Shuaib A., Singh N., Kajil M., Tsigoulis M., and Gupta M. High rates of antiplatelet use in atrial fibrillation patients treated with oral anticoagulation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry. Can J Cardiol. October 2014; 30; 10 (Suppl S): Page S183


Presented at the Canadian Cardiovascular Congress 2014, Scientific Session

Mancini G.B.J., Saldanha C., Shuaib A., Kajil M., Tsigoulis M., and Gupta M. The influence of stroke and bleeding risk on oral anticoagulation use for stroke prevention in patients with atrial fibrillation: Insights from the Stroke Prevention and Rhythm INTerventions in Atrial Fibrillation (SPRINT-AF) registry. Can J Cardiol. October 2014; 30; 10 (Suppl S): Page S289

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2014, Scientific Session

Ha A., Singh N., Verma S., Cox J., Paul Dorian; C Fournier; Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini G.B.J., Saldanha C., Shuaib A., Kajil M., Tsigoulis M., and Gupta M. Is accurate stroke risk assessment with CHADS2 necessary in managing patients with atrial fibrillation? Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry. Circulation; 2014; 130:A15425

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2014, Scientific Session

Gupta M., Singh N., Verma S., Cox J., Dorian P., Fournier C., Gladstone D., Lockwood E., Mancini G.B.J., Saldanha C., Shuaib A., Singh N., Kajil M., Tsigoulis M., and Ha A. High rates of concomitant antiplatelet use in patients with atrial fibrillation treated with oral anticoagulation: Insights from the Stroke Prevention and Rhythm INTerventions in Atrial Fibrillation (SPRINT-AF) registry. Circulation; 2014; 130:A15439

Poster Available
Members only content. Please register or login to view


Abstracts


Presented at the Canadian Cardiovascular Congress 2013, Scientific Session

Gupta, M., Kajil, M., Tsigoulis, M., Bansal A., Hirjikaka, S., Singh, N,. and Verma, S. Adherence to evidence based medications in South Asian and White Caucasian patients with coronary heart disease: Insight from the PRACTICE RegistryCan J Cardiol. 2013; 29, Issue 10 (Suppl S): Page S275

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2013, Scientific Session

Gupta, M., Kajil, M., Tsigoulis, M., Singh, N,. and Verma, S. Characteristics of Non-Diabetic Middle-Aged Adults With Chronic Kidney Disease (CKD) – Insight From the Paradigm Registry. Can J Cardiol. 2013; 29,Issue 10 (Suppl S): S326-S327

Poster Available
Members only content. Please register or login to view


Manuscripts

Everett BM., Pradhan AD., Solomon DH., Paynter N., Macfadyen J., Zaharris E., Gupta M., Clearfield M., Libby P., Hasan AA., Glynn RJ., and Ridker PM. Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis. Am Heart J. 2013;166:199-207 e115.

Abstracts


Presented at the American College of Cardiology 2012, Scientific Session

Gupta M., Chawla K., Kajil M., Roy S., Tsigoulis M., and Verma S. Contemporary Trends in Hypertension in Canada: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. JACC. 2012; 59 E1724.

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2012, Scientific Session

Gupta M., Kajil M., Tsigoulis M., and Verma S. Prevalence of Impaired Fasting Glucose in Healthy Middle-Aged Adults: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Can J Cardiol. 2012; 28, Issue 5 (Suppl S): S243.

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2012, Scientific Session

Saha D., Tsigoulis M., Verma S., and Gupta M. Prevalence of Risk Factors and Occult Coronary Disease in South Asians Referred to a Specialized Risk Assessment Clinic. Can J Cardiol. 2012; 28, Issue 5 (Suppl S): S245-246.

Poster Available
Members only content. Please register or login to view


Presented at the Canadian Cardiovascular Congress 2012, Scientific Session

O’Neill B.J., Gupta M., Verma S., Tsigoulis M., Mann U., and Leiter L.A. Snapshot of Glycemic Management in Patients Presenting With Acute Coronary Syndromes: Survey of Care by Cardiologists and Endocrinologists Across Canada. Can J Cardiol. 2012; 28, Issue 5 (Suppl S): S401-402.


Presented at the American Heart Association 2012, Scientific Session

Kajil, M., Tsigoulis M., Verma S., and Gupta M. Prevalence of Metabolic Syndrome in Healthy Middle-Aged Adults: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012; 126: A11095

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2012, Scientific Session

Kajil, M., Tsigoulis M., Verma S., and Gupta M. Prevalence of Impaired Fasting Glucose in Healthy Middle-Aged Adults: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012;126:A11116

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2012, Scientific Session

Gupta, A., Kajil M., Singh N., Tsigoulis M., Verma S., and Gupta M. Variability in Traditional and Novel Cardiovascular Risk Factors by Ethnic Origin: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study. Circulation. 2012; 126: A14502

Poster Available
Members only content. Please register or login to view


Manuscripts

Gupta M., Teoh H., Tisgoulis M., Quan A., Braga MFB., and Verma S. The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients. Experimental and Clinical Cardiology. Winter 2012, Volume 17 Issue 4: 191-196.

Verma S., Gupta M., Ridker P. Therapeutic Targeting of Inflammation in Atherosclerosis: We Are Getting Closer. Can J Cardiol. 2012 Dec; 28 (6): 619-622.

Gupta M, Singh N, Tsigoulis M, Kajil M, Hirjikaka S, Quan A, Teoh H., and Verma S. Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management. Can J Cardiol. 28 (2012) 14-19.

Abstracts


Presented at the American College of Cardiology 2011, Scientific Session

Gupta M, Tsigoulis M, Hirjikaka S, Kajil M, Mamdani M, and Verma S. Comparative evaluation of adipokines, inflammatory markers and cardiovascular outcomes in Asian Indians vs. European whites with coronary heart disease: results from the PRACTICE registry. JACC. 2011; 57,14 (Suppl A): 95


Presented at the Canadian Cardiovascular Congress 2011, Scientific Session

Gupta M., Ostrovski I., Kajil M., Tsigoulis M. and Verma S. Who receives ASA for primary prevention in Canada?: Insight from the Primary cARe AuDIt of Global risk Management (PARADIGM) study. Can J Cardiol. 2011; 27, Issue 5,(Suppl S):68S.


Presented at the Canadian Cardiovascular Congress 2011, Scientific Session

Roy S., Gupta A., Chawla K., Tsigoulis S., Verma S., and Gupta M. Prevalence of risk factors and occult coronary disease in South Asians referred to a specialized risk assessment clinic. Can J Cardiol. 2011; 27, Issue 5,(Suppl S): 68-69S.


Presented at the Canadian Cardiovascular Congress 2011, Scientific Session

Chawla K, Kajil M., Roy S., Tsigoulis M., Verma S., Gupta M. Contemporary trends in hypertension in Canada: Insight from the Primary cARe AuDIt of global risk Management (PARADIGM) study. Can J Cardiol. 2011; 27, Issue 5, (Suppl S): 67-68S.


Presented at the Canadian Cardiovascular Congress 2011, Scientific Session

Mancini J. G.B, Verma S, Tsigoulis M, Kajil M, Mamdani M, and Gupta M. Cardiovascular (CV) risk stratification by Primary Care Physicians (PCPs) using Framingham risk score (FRS) and in-office carotid ultrasound: Preliminary results from the Primary Care Audit of Global Risk Management (PARADIGM) study. JACC. 2011; 57.14 (Suppl A): 37.

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2011, Scientific Session

Gupta M., Ostrovski I., Kajil M., Tsigoulis M. and Verma S. Who receives ASA for primary prevention in Canada?: Insight from the Primary cARe AuDIt of Global risk Management (PARADIGM) study. Circulation. 2011; 124 Issue 21

Poster Available
Members only content. Please register or login to view


Presented at the American Heart Association 2011, Scientific Session

Trop S., Marshall J., Quan A., Rotstein O., Gupta M., Gupta N., Garg V., Slutsky A., Mazer D., Dumont D., Bourdeau A., Verma S. Prolonged Cardiovascular System Failure in South Asians Undergoing Cardiopulmonary Bypass Correlates with Prolonged Inflammation and Increased TLR4-mediated Signaling. Circulation. 2011; 124: A11527.


Manuscripts

Mancini J.G.B, Baker S., Bergeron J., Fitchett D., Frohlich J., Genest J., Gupta M., Hegele R., Ng D. and Pope J. Diagnosis, prevention and management of statin adverse effects and intolerance: Proceedings of a Canadian working group consensus conference. Can J Cardiol. 27 (2011) 635-662.

Bainey K., Norris C., Gupta M., Southern D., Galbraith D., Knudtson M.L, and Graham M. Altered health status and quality of life in South Asians with coronary artery disease. Alberta and Brampton, Ontario Am Heart J. 2011; 162:501-6.

Gupta M, Martineau P, Tran T, Despres J-P, Gaw A, De Teresa E, Farsang C, Gensini G.F, Leiter L, Blanco-Colio L.M, Egido J, and Langer A. Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European Origin: insights from the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. J Clin Pharmacol May 24, 2011. 0091270011407196.

Leiter L, Fitchett D, Gilbert R, Gupta M, Mancini J, McFarlane P, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox J, Despres J-P, Genest J, Harris S, Lau D, Lewanczuk R, Liu P, Lonn E, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin S, Sharma AM, Steele A, Stone J, Tardif J-C, Tobe S, and Ur E. Identification and management of cardiometabolic risk in Canada. Detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol. 27(2011) cl-c33.

Grace S.L., Russell K., Reid R., Oh P., Anand S., Rush J., Williamson K., Gupta M., Alter D.A., and Stewart D. E. Effect of cardiac rehabilitation referral strategies on utilization rates: A prospective, controlled study. Archives of Internal Medicine, 2011: 171(3), 235-241. February.


Abstracts 2010


Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Tsigoulis M, Hirjikaka S, Kajil M, Mamdani M, and Verma S. Cardiovascular outcomes in south Asians with coronary heart disease – Preliminary results from the PRACTICE Registry. Can J Cardiol. 2010;26(Suppl D):56D


Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Teoh H, Yi Q, Strauss M, Tsigoulis M, Verma S, and Eikelboom JW. Fibrinolytic function in south Asians and Europeans with coronary heart disease: Insights from the PRACTICE Registry. Can J Cardiol. 2010;26(Suppl D):57D


Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Kajil M, Hirjikaka S, Tsigoulis M, Nisenbaum R, Mamdani M, and Verma S. Accuracy of cardiovascular (CV) risk stratification by Canadian primary care physicians; Preliminary results from the Primary cARe AuDIt of Global risk Management (PARADIGM) Study. Can J Cardiol. 2010;26(Suppl D):66D


Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Gupta M, Teoh H, Kajil M, Tsigoulis M, Quan A, Braga M, and Verma S. Rosiglitazone-based therapy reduces inflammatory biomarkers in diabetic, hypertensive patients compared to a metformin and glyburide based-regimen: The ROSITEL randomized trial. Can J Cardiol. 2010;26(Suppl D):125D


Presented at the Canadian Cardiovascular Congress 2010, Scientific Session

Verma S, Gupta M, Holmes DT, Xu L, Teoh H, Gupta S, Yusuf S, and Lonn E. Plasma renin activity predicts cardiovascular events and mortality in the heart outcomes prevention evaluation (HOPE) study. Can J Cardiol. 2010;26(Suppl D):76D


Presented at the American Heart Association 2010, Scientific Session

Gupta M., Kajil M., Hirjikaka S., Tsigoulis M., Mancini G.B., Nisenbaum R., Mamdani M., and Verma S. Accuracy of cardiovascular (CV) risk stratification by Canadian primary care physicians; Preliminary results from the Primary cARe AuDIt of Global risk Management (PARADIGM) Study. Circulation 2010; 122: A16946.


Manuscripts 2010

Gupta M., Szmitko P.E., Tsigoulis M., Braga M., Kajil M., Hirjikaka S., Quan A., Teoh H. and Verma S: Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease. JCVP 2010 Sep;56(3): 241-5



Abstracts 2009


Presented at the Canadian Cardiovascular Congress 2009, Scientific Session

Gupta M, Kajil M, Teoh H, Hirjikaka S, Quan A, Tsigoulis M, Verma S. Primary care physician perspectives regarding HS-CRP in global risk assessment and treatment. Can J Cardiol. 2009. 769.258. B.Vol.25 Suppl.B1B-352.


Presented at the Canadian Cardiovascular Congress 2009, Scientific Session

Gupta S, Kajil M, Teoh H, Hirjikaka S, Quan A, Tsigoulis M, and Verma S. Trends in contemporary cardiovascular risk assessment in Canada. Can J Cardiol. 2009; 25(Suppl B); pp274.


Presented at the American Heart Association 2009, Scientific Session

Gupta M, Tsigoulis M, Kajil M, Hirjikaka S, Quan A, Teoh H and Verma S (2009) Trends in contemporary cardiovascular risk assessment in Canada: Results of the PARADIGM perceptions study. Circulation 120 (18 Suppl)S411-412.


Presented at the American Heart Association 2009, Scientific Session

Verma S, Gupta M, Holmes T, Teoh H, Xu L, Yusuf S, and Lonn E. Plasma rennin activity is associated with increased cardiovascular events and mortality in the HOPE study. Circulation 2009; 120: S453.


Manuscripts 2009

Fitchett D, Eikelboom J, Fremes A, Mazer S, Singh A, Bittira B, Brister A, Graham JJ, Gupta M, Karkouti K, Lee A, Love M, McArthur R, Peterson M, Verma S, and Yau, TM. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society. Can J Cardiol: 2009: 25(12): pp 683-9.

Gupta M, Braga MF, Teoh H, Tsigoulis M, and Verma S. Statin effects on LDL and HDL cholesterol in South Asian and white populations. J Clin Pharmacol. 2009 Jul;49(7):831-7.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, and Verma S. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9.



Manuscripts 2008

Gupta M, Braga MB, Verma S. A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. Can J Cardiol. 2008 Oct;24(10):e65-9.

Verma S, and Gupta MK. Aliskiren improves nitric oxide bioavailability and limits atherosclerosis. Hypertension. 2008 Sep;52(3):467-9.

Teoh H, Quan A, Bang KW, Wang G, Lovren F, Vu V, Haitsma JJ, Szmitko PE, Al-Omran M, Wang CH, Gupta M, Peterson MD, Zhang H, Chan L, Freedman J, Sweeney G, and Verma S. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E658-64.



Abstracts 2007


Presented at the Canadian Cardiovascular Congress 2007, Scientific Session

Gupta M,and Braga M. Prevalence and gender distribution of metabolic syndrome in South Asians and White Caucasians with coronary heart disease. Can J Cardiol 2007;23 (Suppl C):188C


Manuscripts 2007

Gupta M, Verma S, and Mancini GB. ACE inhibitors: back to prime time? Heart. 2007 Sep;93(9):1015-6.



Abstracts 2006

Presented at the Canadian Cardiovascular Congress 2006, Scientific Session

Gupta M, Braga M, Gillett M, Desai N, and Verma S. LDL response to statins does not differ between South Asians (SA) and white Caucasians (WC). Can J Cardiol. 2006; 22(Suppl D).


Manuscripts 2006

Gupta M, Singh N, and Verma S. South Asians and cardiovascular risk: What clinicians should know. Circulation. 2006; 113:924-92



Abstracts 2005

Presented at the Canadian Cardiovascular Congress 2005, Scientific Session

Gupta M, Evelegh M, Gillet J, and Tse J. Skin tissue cholesterol and C-Reactive Protein are associated with metabolic syndrome in subjects with coronary heart disease. Can J Cardiol 2005;21(Suppl C):172C.



Abstracts 2004

Presented at the Canadian Cardiovascular Congress 2004, Scientific Session

Gupta M, and Tsigoulis M. Differences in traditional and novel risk factors in South Asians and Europeans with coronary disease despite similar use of evidence based treatments. Can J Cardiol 2004:20 (Suppl D): 129D.

Presented at the Canadian Cardiovascular Congress 2004, Scientific Session

Gupta M, and Tsigoulis M. NCEP and WHO definitions are equally predictive of metabolic syndrome in South Asian but not European Canadians with coronary disease: Findings from the PRACTICE registry. Can J Cardiol 2004; 20 (Suppl D): 171D

Presented at the Canadian Cardiovascular Congress 2004, Scientific Session

Gupta M, Tsigoulis M, and Evelegh M. Skin tissue cholesterol is associated with angina, diabetes, and history of Stroke/TIA in subjects with coronary artery disease. Can J Cardiol 2004; 20(Suppl D):122D.